GILDER GAGNON HOWE & CO LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 902464
New York, NY
Position in ADPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
8,764
+54.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GILDER GAGNON HOWE & CO LLC holds $154,638,628 across 4 Diagnostics & Research names. ADPT ranks #4 (0.0% of the industry book) .
All Filings in ADPT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 35,056 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | — | 22,719 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 24,998 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | — | 1,245,111 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | — | 1,233,514 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | — | 1,224,118 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | — | 1,215,525 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | — | 1,169,520 | Shares | Defined | 2023-05-15 | |
| 2021-12-31 | — | 942,666 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | — | 1,969,726 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | — | 2,049,963 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | — | 2,384,205 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | — | 2,374,798 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | — | 2,397,279 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | — | 2,455,269 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | — | 2,279,250 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||